Unknown

Dataset Information

An environmental epigenetic study of ADRB2 5'-UTR methylation and childhood asthma severity.


ABSTRACT:

Background

Beta-2 adrenergic receptor (ADRB2) is the primary target of both short- and long-acting beta-agonist asthma medications. ADRB2 5'-UTR methylation changes in blood have the potential to act as a surrogate biomarker of responsiveness to beta-agonist treatment and childhood asthma severity.

Objective

To study the association between ADRB2 5'-UTR methylation, NO (2) exposure and childhood asthma severity.

Methods

We compared ADRB2 5'-UTR methylation levels in blood between 60 children with mild asthma and 122 children with severe asthma using methylation-specific PCR. We also investigated potential joint effects between NO (2) exposure and ADRB2 5'-UTR methylation.

Results

We found a significant association between intermediate (OR: 4.11, 95% CI: 1.58-

SUBMITTER: Fu A 

PROVIDER: S-EPMC3673701 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature